REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC <Origin Href="QuoteRef">SPI.L</Origin>
RNS Number : 8453UNomura International PLC27 October 2017FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Nomura International PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
NA
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Spire Healthcare Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
NA
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
26 Oct 2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
Yes, Mediclinic International Plc
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
10,206,923
2.545
3,970,240
0.990
(2) Cash-settled derivatives:
3,970,240
0.990
10,206,923
2.545
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
0
0.000
0
0.000
TOTAL:
14,177,163
3.535
14,177,163
3.535
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
Ordinary Shares
Purchase
94
2.9300
Ordinary Shares
Purchase
12,627
2.9308
Ordinary Shares
Purchase
236,000
2.9409
Ordinary Shares
Purchase
200,070
2.9478
Ordinary Shares
Purchase
730,000
2.9811
Ordinary Shares
Purchase
14,981
2.9838
Ordinary Shares
Sale
8,736
2.9287
Ordinary Shares
Sale
705
2.9297
Ordinary Shares
Sale
1,376
2.9348
Ordinary Shares
Sale
10,379
2.9387
Ordinary Shares
Sale
41,549
2.9466
Ordinary Shares
Sale
148,763
2.9503
Ordinary Shares
Sale
4,036
2.9796
Ordinary Shares
Sale
17,762
3.0110
Ordinary Shares
Sale
8,113
3.0298
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit
Ordinary Shares
SWAP
Long
8,736
2.9290
Ordinary Shares
SWAP
Long
705
2.9300
Ordinary Shares
SWAP
Long
1,376
2.9350
Ordinary Shares
SWAP
Long
10,379
2.9389
Ordinary Shares
SWAP
Long
41,549
2.9467
Ordinary Shares
SWAP
Long
148,763
2.9503
Ordinary Shares
SWAP
Long
4,036
2.9800
Ordinary Shares
SWAP
Long
17,762
3.0112
Ordinary Shares
SWAP
Long
8,113
3.0300
Ordinary Shares
SWAP
Short
94
2.9300
Ordinary Shares
SWAP
Short
12,627
2.9306
Ordinary Shares
SWAP
Short
236,000
2.9404
Ordinary Shares
SWAP
Short
200,070
2.9478
Ordinary Shares
SWAP
Short
730,000
2.9811
Ordinary Shares
SWAP
Short
14,981
2.9835
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
NO
Date of disclosure:
27 October 2017
Contact name:
Kyere Tabiri
Telephone number:
020 7102 1267
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNSThe company news service from the London Stock ExchangeENDRETFELFSWFWSEFS
Recent news on Spire Healthcare
See all newsREG - eEnergy Group PLC Spire Healthcare Grp - Major Contract Win with Spire Healthcare
AnnouncementREG - Spire Healthcare Grp - Capital Markets Event
AnnouncementREG - Spire Healthcare Grp - Notice of AGM
AnnouncementREG - Spire Healthcare Grp - Block listing Interim Review
AnnouncementREG - Spire Healthcare Grp - Portfolio management: Spire Tunbridge Wells
Announcement